Natera Current Ratio 2014-2025 | NTRA
Current and historical current ratio for Natera (NTRA) from 2014 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Natera current ratio for the three months ending June 30, 2025 was 3.72.
| Natera Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $1.43B | $0.39B | 3.72 |
| 2025-03-31 | $1.42B | $0.37B | 3.87 |
| 2024-12-31 | $1.38B | $0.34B | 4.00 |
| 2024-09-30 | $1.32B | $0.30B | 4.39 |
| 2024-06-30 | $1.30B | $0.32B | 4.14 |
| 2024-03-31 | $1.26B | $0.31B | 4.12 |
| 2023-12-31 | $1.26B | $0.31B | 4.10 |
| 2023-09-30 | $1.27B | $0.29B | 4.37 |
| 2023-06-30 | $1.07B | $0.28B | 3.85 |
| 2023-03-31 | $1.13B | $0.29B | 3.88 |
| 2022-12-31 | $1.21B | $0.31B | 3.90 |
| 2022-09-30 | $0.83B | $0.27B | 3.10 |
| 2022-06-30 | $0.90B | $0.25B | 3.58 |
| 2022-03-31 | $0.98B | $0.23B | 4.24 |
| 2021-12-31 | $1.09B | $0.22B | 4.99 |
| 2021-09-30 | $1.19B | $0.20B | 5.97 |
| 2021-06-30 | $0.74B | $0.20B | 3.74 |
| 2021-03-31 | $0.79B | $0.17B | 4.74 |
| 2020-12-31 | $0.86B | $0.20B | 4.33 |
| 2020-09-30 | $0.92B | $0.20B | 4.68 |
| 2020-06-30 | $0.66B | $0.18B | 3.78 |
| 2020-03-31 | $0.50B | $0.18B | 2.82 |
| 2019-12-31 | $0.52B | $0.18B | 2.91 |
| 2019-09-30 | $0.32B | $0.14B | 2.35 |
| 2019-06-30 | $0.32B | $0.13B | 2.54 |
| 2019-03-31 | $0.21B | $0.11B | 1.85 |
| 2018-12-31 | $0.24B | $0.11B | 2.11 |
| 2018-09-30 | $0.25B | $0.10B | 2.44 |
| 2018-06-30 | $0.17B | $0.10B | 1.69 |
| 2018-03-31 | $0.19B | $0.10B | 1.80 |
| 2017-12-31 | $0.18B | $0.11B | 1.71 |
| 2017-09-30 | $0.17B | $0.09B | 1.85 |
| 2017-06-30 | $0.12B | $0.10B | 1.25 |
| 2017-03-31 | $0.14B | $0.09B | 1.51 |
| 2016-12-31 | $0.17B | $0.10B | 1.81 |
| 2016-09-30 | $0.21B | $0.10B | 2.21 |
| 2016-06-30 | $0.24B | $0.10B | 2.48 |
| 2016-03-31 | $0.25B | $0.08B | 2.95 |
| 2015-12-31 | $0.25B | $0.08B | 3.12 |
| 2015-09-30 | $0.25B | $0.04B | 7.03 |
| 2015-06-30 | $0.09B | $0.04B | 2.23 |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2013-12-31 | $0.05B | $0.02B | 2.08 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $27.391B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.291B | 27.23 |
| HCA Healthcare (HCA) | United States | $108.759B | 18.01 |
| CVS Health (CVS) | United States | $100.272B | 11.53 |
| Elevance Health (ELV) | United States | $70.623B | 10.36 |
| Cencora (COR) | United States | $69.932B | 22.56 |
| DiDi Global (DIDIY) | China | $25.980B | 21.23 |
| Labcorp Holdings (LH) | United States | $20.950B | 15.98 |
| Medpace Holdings (MEDP) | United States | $16.595B | 41.20 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| ICON (ICLR) | Ireland | $12.852B | 12.75 |
| Solventum (SOLV) | United States | $12.405B | 12.04 |
| CochLear (CHEOY) | Australia | $12.093B | 0.00 |
| Viatris (VTRS) | United States | $11.656B | 4.34 |
| Revvity (RVTY) | United States | $10.292B | 18.95 |
| Charles River Laboratories (CRL) | United States | $8.271B | 15.93 |
| HealthEquity (HQY) | United States | $8.074B | 32.31 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.226B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.746B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.977B | 35.63 |
| Bausch + Lomb (BLCO) | Canada | $5.508B | 36.16 |
| Sotera Health (SHC) | United States | $4.455B | 21.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.039B | 70.93 |
| Alignment Healthcare (ALHC) | United States | $3.268B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.757B | 34.68 |
| Concentras Parent (CON) | United States | $2.479B | 15.47 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.061B | 7.96 |
| Progyny (PGNY) | United States | $1.923B | 37.92 |
| Pediatrix Medical (MD) | United States | $1.883B | 11.25 |
| Establishment Labs Holdings (ESTA) | $1.883B | 0.00 | |
| PACS (PACS) | United States | $1.878B | 0.00 |
| Organon (OGN) | United States | $1.763B | 1.92 |
| Teladoc Health (TDOC) | United States | $1.336B | 0.00 |
| Omada Health (OMDA) | $1.169B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.081B | 17.28 |
| Embecta (EMBC) | United States | $0.807B | 4.72 |
| CareDx (CDNA) | United States | $0.803B | 13.13 |
| InnovAge Holding (INNV) | United States | $0.718B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.685B | 9.45 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Sonida Senior Living (SNDA) | United States | $0.604B | 0.00 |
| Pomdoctor - (POM) | China | $0.540B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.523B | 0.00 |
| So-Young (SY) | China | $0.449B | 0.00 |
| CryoPort (CYRX) | United States | $0.420B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 18.07 |
| Auna S.A (AUNA) | Luxembourg | $0.401B | 6.02 |
| Charming Medical (MCTA) | $0.374B | 0.00 | |
| Strata Critical Medical (SRTA) | United States | $0.362B | 0.00 |
| KindlyMD (NAKA) | United States | $0.339B | 0.00 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| SBC Medicals (SBC) | United States | $0.327B | 7.16 |
| Agilon Health (AGL) | United States | $0.277B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.225B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.89 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |